Max Healthcare Inst

₹810 14.8 | 1.9%

WEBSITE BSE:543220 NSE : MAXHEALTH 10 May, 16:01

Market Cap ₹78725 Cr.

Stock P/E 74.4

P/B 9.7

Current Price ₹810

Book Value ₹ 83.7

Face Value 10

52W High ₹909

Dividend Yield 0.12%

52W Low ₹ 478.6

Edit Ratio

Max Healthcare Inst Research see more...

Overview Inc. Year: Industry: Hospital & Healthcare Services

Max Healthcare Institute Ltd provides healthcare services in India. It offers services in various specialities, such as cancer care/oncology, cardiac sciences, neuro sciences, liver transplant and biliary sciences, orthopaedics, nephrology, kidney transplant, bone marrow transplant, bariatric/weight reduction surgical treatment, laparoscopic surgery, urology, gastroenterology, and aesthetic and reconstructive surgical procedure. The business enterprise additionally provides Max@Home, a platform that gives fitness and well-being services at home; and MaxLab, which provides diagnostic offerings to sufferers outside its network of hospitals via diverse channels comprising third party clinic laboratory management. It operated a network of 17 healthcare facilities, including tertiary and quaternary care hospitals at Saket, Patparganj, Vaishali, Rajendra Place, and Shalimar Bagh in Delhi National Capital Region; one each in Mumbai, Mohali, Bathinda, and Dehradun; a secondary care sanatorium in Gurugram; and day care centres at Noida, Lajpat Nagar, and Panchsheel Park in Delhi National Capital Region and one in Mohali, Punjab. The organization is primarily based in Gurugram, India.

Max Healthcare Inst Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Max Healthcare Inst Quarterly Results

#(Fig in Cr.)	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Net Sales	1019	976	937	1067	1139	1142	1215	1285	1363	1335
Other Income	30	47	26	31	24	45	40	41	45	46
Total Income	1050	1023	964	1098	1163	1186	1255	1326	1409	1381
Total Expenditure	779	728	729	802	818	828	874	948	976	949
Operating Profit	270	294	235	296	345	359	381	379	433	432
Interest	27	25	22	22	22	20	20	19	9	11
Depreciation	54	55	58	57	58	57	60	56	58	61
Exceptional Income / Expenses	-8	-1	0	0	0	0	0	0	0	0
Profit Before Tax	182	213	154	216	265	281	301	303	366	360
Provision for Tax	37	23	31	44	-192	59	50	63	90	70
Profit After Tax	145	190	124	173	457	222	251	240	277	289
Adjustments	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	145	190	124	173	457	222	251	240	277	289
Adjusted Earnings Per Share	1.5	2	1.3	1.8	4.7	2.3	2.6	2.5	2.8	3

Max Healthcare Inst Profit & Loss

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	944	1134	1434	1608	1729	1691	1059	2508	3937	4563	5198
Other Income	23	27	36	42	55	67	53	135	132	152	172
Total Income	968	1161	1471	1651	1784	1758	1112	2643	4068	4715	5371
Total Expenditure	915	1058	1331	1468	1616	1546	970	2124	2998	3335	3747
Operating Profit	53	102	140	183	167	212	142	519	1070	1380	1625
Interest	62	61	68	100	99	101	83	179	101	84	59
Depreciation	55	78	91	96	94	103	46	174	221	232	235
Exceptional Income / Expenses	0	0	0	0	0	0	0	-234	-9	0	0
Profit Before Tax	-64	-37	-19	-12	-26	8	13	-69	739	1064	1330
Provision for Tax	0	0	4	-11	2	9	-0	46	134	-40	273
Profit After Tax	-65	-37	-23	-1	-29	-0	13	-115	605	1104	1057
Adjustments	0	0	0	17	8	-3	46	-23	0	0	0
Profit After Adjustments	-65	-37	-23	16	-21	-3	59	-138	605	1104	1057
Adjusted Earnings Per Share	-1.5	-0.8	-0.4	0.3	-0.4	-0.1	1.1	-1.4	6.2	11.4	10.9

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	16%	63%	21%	0%
Operating Profit CAGR	29%	113%	53%	0%
PAT CAGR	82%	340%	0%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	69%	52%	NA%	NA%
ROE Average	16%	8%	5%	0%
ROCE Average	15%	10%	8%	5%

Max Healthcare Inst Balance Sheet

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	549	831	1145	1192	1167	963	2553	5639	6282	7410
Minority's Interest	0	0	-17	-73	-133	0	0	0	0	0
Borrowings	346	332	649	772	849	890	106	843	629	497
Other Non-Current Liabilities	65	7	846	875	944	361	304	1285	1520	1150
Total Current Liabilities	320	282	422	380	478	1140	1010	777	757	1046
Total Liabilities	1280	1453	3045	3146	3304	3355	3974	8543	9189	10102
Fixed Assets	775	740	2273	2244	2227	2192	851	6536	7018	7039
Other Non-Current Assets	272	330	482	552	645	715	207	883	1171	1120
Total Current Assets	233	383	290	349	432	447	2915	1124	1000	1943
Total Assets	1280	1453	3045	3146	3304	3355	3974	8543	9189	10102

Max Healthcare Inst Cash Flow

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	19	10	25	11	15	9	322	111	627	309
Cash Flow from Operating Activities	73	64	723	156	82	89	77	118	741	1209
Cash Flow from Investing Activities	-31	-194	-1340	-104	-100	-17	-2641	-73	-764	-1187
Cash Flow from Financing Activities	-52	145	603	-48	12	-74	2353	191	-294	-289
Net Cash Inflow / Outflow	-9	16	-14	4	-6	-2	-210	236	-317	-266
Closing Cash & Cash Equivalent	10	25	11	15	9	8	111	627	309	43

Max Healthcare Inst Ratios

#	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	-1.51	-0.76	-0.42	0.29	-0.39	-0.06	1.1	-1.42	6.24	11.37
CEPS(Rs)	-0.22	0.85	1.29	1.75	1.22	1.91	1.09	0.62	8.52	13.76
DPS(Rs)	0	0	0	0	0	0	0	0	0	1
Book NAV/Share(Rs)	11.32	17.01	21.47	22.19	21.72	17.93	47.52	58.1	64.57	75.89
Core EBITDA Margin(%)	3.17	6.64	7.22	8.73	6.52	8.6	8.37	15.3	23.84	26.9
EBIT Margin(%)	-0.22	2.13	3.4	5.42	4.21	6.48	9.07	4.42	21.33	25.15
Pre Tax Margin(%)	-6.81	-3.27	-1.32	-0.78	-1.53	0.49	1.21	-2.74	18.77	23.31
PAT Margin (%)	-6.85	-3.27	-1.58	-0.09	-1.66	-0.01	1.22	-4.57	15.37	24.19
Cash Profit Margin (%)	-0.97	3.65	4.78	5.85	3.8	6.06	5.53	2.38	20.99	29.27
ROA(%)	-5.05	-2.71	-1.01	-0.05	-0.89	-0.01	0.35	-1.83	6.82	11.44
ROE(%)	-13.37	-5.64	-2.29	-0.12	-2.44	-0.02	0.73	-2.8	10.19	16.19
ROCE(%)	-0.2	2.11	3.05	4.34	3.46	5.33	3.57	2.22	12.38	15.32
Receivable days	63.55	54.39	48.61	50.32	52.01	66.97	79.05	33.62	34.83	28.86
Inventory Days	5.87	5.43	5.31	5.26	5.42	5.86	9.1	5.87	5.34	5.5
Payable days	170.84	162.82	170.36	185.81	205.78	279.46	395.74	188.92	173.98	195.48
PER(x)	0	0	0	0	0	0	0	0	55.59	38.8
Price/Book(x)	0	0	0	0	0	0	0	3.55	5.37	5.81
Dividend Yield(%)	0	0	0	0	0	0	0	0	0	0.23
EV/Net Sales(x)	1.01	0.78	0.92	0.86	0.83	0.9	1.2	8.04	8.6	9.19
EV/Core EBITDA(x)	17.92	8.61	9.45	7.6	8.53	7.2	8.99	38.89	31.65	30.38
Net Sales Growth(%)	0	20.03	26.51	12.14	7.52	-2.2	-37.37	136.82	56.96	15.9
EBIT Growth(%)	0	1281.86	102.36	78.7	-16.41	50.37	-12.38	15.4	657.85	36.65
PAT Growth(%)	0	42.69	38.97	93.81	-1952.14	99.34	6894.74	-986.91	628.43	82.38
EPS Growth(%)	0	49.91	44.08	169.34	-231.6	85.52	2060.71	-229.69	538.21	82.14
Debt/Equity(x)	0.88	0.51	0.7	0.73	0.84	1.04	0.33	0.16	0.12	0.08
Current Ratio(x)	0.73	1.36	0.69	0.92	0.9	0.39	2.89	1.45	1.32	1.86
Quick Ratio(x)	0.68	1.29	0.63	0.86	0.84	0.37	2.86	1.38	1.24	1.79
Interest Cover(x)	-0.03	0.39	0.72	0.87	0.73	1.08	1.15	0.62	8.33	13.68
Total Debt/Mcap(x)	0	0	0	0	0	0	0	0.05	0.02	0.01

Max Healthcare Inst Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	60.68	50.64	50.64	23.8	23.78	23.77	23.76	23.76	23.75	23.75
FII	16.67	14.59	23.34	49.26	50.14	51.94	59.88	60.37	60.68	57.32
DII	15.68	17.56	19.42	21.18	20.48	19.36	11.9	11.41	11.58	14.97
Public	6.97	17.2	6.61	5.76	5.61	4.93	4.46	4.46	3.99	3.96
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	58.84	49.1	49.1	23.08	23.08	23.08	23.08	23.08	23.08	23.08
FII	16.16	14.15	22.63	47.76	48.67	50.43	58.17	58.66	58.97	55.71
DII	15.2	17.03	18.83	20.54	19.88	18.79	11.56	11.09	11.25	14.55
Public	6.76	16.68	6.4	5.59	5.45	4.78	4.33	4.33	3.88	3.85
Others	0	0	0	0	0	0	0	0	0	0
Total	96.96	96.96	96.96	96.97	97.07	97.09	97.14	97.16	97.18	97.19

Pros

Company has reduced debt.
Company is almost debt free.

Cons

Promoter holding is low: 23.75%.
Company has a low return on equity of 8% over the last 3 years.
Debtor days have increased from 173.98 to 195.48days.
Stock is trading at 9.7 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Max Healthcare Inst News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

Current Price: 135/-

Lakeshore Hospital

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Max Healthcare Inst

Add Watchlist

Max Healthcare Inst Research see more...

Overview Inc. Year: Industry: Hospital & Healthcare Services

Max Healthcare Inst Share Price

Alert Data

Quarterly Price

Peer Comparison

Max Healthcare Inst Quarterly Results

Max Healthcare Inst Profit & Loss

Growth Rates

Max Healthcare Inst Balance Sheet

Max Healthcare Inst Cash Flow

Max Healthcare Inst Ratios

Max Healthcare Inst Shareholding Pattern

Max Healthcare Inst News

Top Unlisted Companies & InstaBuy Companies

Lakeshore Hospital

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!